S100A10: Potential Drug Target and Biomarker (G6281)

Target Name: S100A10

NCBI ID: G6281

S100A10

S100A10: Potential Drug Target and Biomarker

S100A10, also known as S100 calcium binding protein A10, is a protein that is expressed in a variety of tissues throughout the body. It is a member of the S100 family of proteins, which are known for their ability to interact with calcium ions. One of the unique features of S100A10 is its ability to interact with light polypeptide (p11), a protein that is also known as calpactin I.

S100A10 has been shown to play a role in a variety of physiological processes, including cell signaling, tissue repair, and inflammation. It is also a potential drug target, which means that it may be a target for therapeutic intervention.

One of the ways that S100A10 is involved in signaling is through its role in the regulation of cell signaling pathways. S100A10 has been shown to interact with a variety of signaling proteins, including TGF-β1, NF-kappa-B, and p53. These interactions allow S100A10 to regulate the activity of these proteins and ultimately influence cell behavior.

S100A10 is also involved in the regulation of tissue repair processes. When cells are damaged or damaged tissue is removed, S100A10 can help to coordinate the recruitment of repair factors to the site of injury. This is important for ensuring that the body is able to repair damaged tissue and reduce the risk of chronic inflammation.

In addition to its role in cell signaling and tissue repair, S100A10 is also involved in the regulation of inflammation. It has been shown to interact with a variety of cytokines, including TNF-伪, IL-1, and IL-6. These interactions allow S100A10 to regulate the activity of these cytokines and ultimately influence the inflammatory response.

S100A10 is also a potential biomarker for a variety of diseases. For example, it has been shown to be elevated in the blood of individuals with certain types of cancer, such as breast cancer and colon cancer. This suggests that S100A10 may be a useful biomarker for the detection and diagnosis of these diseases.

In conclusion, S100A10 is a protein that is involved in a variety of physiological processes throughout the body. It is a potential drug target and may be a useful biomarker for the detection and diagnosis of a variety of diseases. Further research is needed to fully understand the role of S100A10 in these processes and to develop effective treatments.

Protein Name: S100 Calcium Binding Protein A10

Functions: Because S100A10 induces the dimerization of ANXA2/p36, it may function as a regulator of protein phosphorylation in that the ANXA2 monomer is the preferred target (in vitro) of tyrosine-specific kinase

The "S100A10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about S100A10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets